Topic Editors

Department of Radiation Oncology, Northwestern Memorial Hospital, Northwest University Feinberg School of Medicine, Galter Pavilion LC 178, Chicago, IL 60611, USA
Dr. Minsong Cao
Department of Radiation Oncology, UCLA Health, Los Angeles, CA 90095, USA

Advances in Magnetic Resonance Imaging (MRI) and Its Role in Radiation Therapy

Abstract submission deadline
closed (31 August 2023)
Manuscript submission deadline
31 October 2025
Viewed by
79

Topic Information

Dear Colleagues,

This is the second edition of a previous edition on “Advances of MRI in Radiation Oncology”. Radiation oncology treatment planning requires CT data for dose calculation; however, CT lacks soft-tissue visualization and characterization. MR images are best suited for soft tissues, especially liver, pancreas, kidney, prostate, and brain tissues. MR images have been augmented using image fusion, but their accuracy can be questionable. Additionally, MR images do not provide the electron density information needed for dose calculation. Moving structures pose additional challenges in radiation oncology. The active trend in radiation oncology is to use MR images with the help of synthetic CT for image-guided radiation therapy. Integrated MR imaging and linear accelerator system (MRL), which provides the optimum treatment for soft tissue and moving structures, is a new frontier in radiation oncology. The focus of this Special Issue is to review current MR imaging options, as well as imaging-assisted therapies and adaptive therapies, in radiation oncology. This issue will cover MR imaging parameters/sequences in low and high magnetic fields, MR-linacs, synthetic CT, dose calculation, and motion management as well as every aspect of MR use in radiation oncology.

Prof. Dr. Indra J. Das
Dr. Minsong Cao
Topic Editors

Keywords

  • MR imaging
  • MR sequence
  • low and high magnetic-field
  • MR-linac
  • adaptive therapy
  • motion management
  • synthetic CT

Participating Journals

Journal Name Impact Factor CiteScore Launched Year First Decision (median) APC
Biomedicines
biomedicines
4.7 3.7 2013 14.7 Days CHF 2600 Submit
Cancers
cancers
5.2 7.4 2009 18.2 Days CHF 2900 Submit
Current Oncology
curroncol
2.6 2.6 1994 18.4 Days CHF 2200 Submit
Diagnostics
diagnostics
3.6 3.6 2011 18.8 Days CHF 2600 Submit
Journal of Clinical Medicine
jcm
3.9 5.4 2012 19.7 Days CHF 2600 Submit

Preprints is a platform dedicated to making early versions of research outputs permanently available and citable. MDPI journals allow posting on preprint servers such as Preprints.org prior to publication. For more details about reprints, please visit https://www.preprints.org.

Published Papers

This Topic is now open for submission.
Back to TopTop